Reduced RBM4 expression was significantly associated with poor differentiation (P < 0.001), lymph node metastasis (P = 0.026), distant metastasis (P = 0.036) and advanced TNM stage (P = 0.014). The gene discussed is RBM4; the disease is metastatic malignant neoplasm in the lymph nodes.